During the past decade, Gandhi Hospital conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 7 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 7 clinical trials were completed. i.e. 233.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gandhi Hospital" #1 collaborator was "Gilead Sciences" with 4 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator and "Nektar Therapeutics" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Gandhi Hospital" are "Ulcerative Colitis" (5 trials), "Crohn's Disease" (3 trials), "Atopic Dermatitis" (2 trials), "Colitis, Ulcerative" (1 trials) and "Hepatitis C Virus Infection" (1 trials). Many other conditions were trialed in "Gandhi Hospital" in a lesser frequency.

Most popular intervention types in "Gandhi Hospital" are "Drug" (14 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Filgotinib" (5 trials), "Mirikizumab" (3 trials), "Baricitinib" (2 trials) and "LY3471851" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gandhi Hospital" are 13 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Gandhi Hospital". undefined are not yet recruiting, 2 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 5 completed trials in Gandhi Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Gandhi Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".